Dallas Diabetes & Endocrine Center (DDEC) is a clinical research center. The comapny is engaged in providing healthcare services related to metabolic and immunology markets. The services offered by the company include thyroid, pituitary, diabetes, osteoporosis and growth hormone disorders. It also focused on conducting pharmaceutical clinical trials in the specialty of endocrinology. It consists of 14,000 member professional organization of endocrinology practitioners and researchers. In addition, it also provides educational programs on the treatment of diabetes. The company has completed extensive research in all types of insulins such as levemir, lantus, humalog, inhaled insulins and novolog. It was established in1990. DDEC is headquartered in Texas, the US.

Street: 
7777 Forest Lane
City: 
Dallas
Postcode: 
75230
Federal State : 
United States
WebSite: 
www.dallasdiabetes.com
Fax: 
1-972-5667399

Company Index Score

Current Index Score Historical Index Score
  • Dallas Diabetes and Endocrine Center currently scores 50 % in the index.
  • Dallas Diabetes and Endocrine Center is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Dallas Diabetes and Endocrine Center is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets